These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9642544)
41. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Hirohata S; Arinuma Y; Takayama M; Yoshio T Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755 [TBL] [Abstract][Full Text] [Related]
42. [Systemic lupus erythematosus of the nervous system--selected aspects]. Walawska-Hrycek A; Krzystanek E; Rudzińska M Wiad Lek; 2015; 68(1):39-44. PubMed ID: 26094332 [TBL] [Abstract][Full Text] [Related]
43. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285 [TBL] [Abstract][Full Text] [Related]
44. Cognitive impairment in patients with systemic lupus erythematosus. Hanly JG; Fisk JD; Sherwood G; Jones E; Jones JV; Eastwood B J Rheumatol; 1992 Apr; 19(4):562-7. PubMed ID: 1593578 [TBL] [Abstract][Full Text] [Related]
46. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage. López-Longo FJ; Carol N; Almoguera MI; Olazarán J; Alonso-Farto JC; Ortega A; Monteagudo I; González CM; Carreño L Lupus; 2003; 12(11):813-9. PubMed ID: 14667096 [TBL] [Abstract][Full Text] [Related]
47. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus. Koren E; Schnitz W; Reichlin M Arthritis Rheum; 1993 Sep; 36(9):1325-8. PubMed ID: 8216426 [TBL] [Abstract][Full Text] [Related]
48. Neurological Disease in Lupus: Toward a Personalized Medicine Approach. McGlasson S; Wiseman S; Wardlaw J; Dhaun N; Hunt DPJ Front Immunol; 2018; 9():1146. PubMed ID: 29928273 [TBL] [Abstract][Full Text] [Related]
50. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978 [TBL] [Abstract][Full Text] [Related]
51. Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies. Spezialetti R; Bluestein HG; Peter JB; Alexander EL Am J Med; 1993 Aug; 95(2):153-60. PubMed ID: 8356981 [TBL] [Abstract][Full Text] [Related]
52. [Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy]. Weiner SM; Otte A; Uhl M; Brink I; Schumacher M; Peter HH Med Klin (Munich); 2003 Feb; 98(2):79-90. PubMed ID: 12601532 [TBL] [Abstract][Full Text] [Related]
53. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995 [TBL] [Abstract][Full Text] [Related]
54. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560 [TBL] [Abstract][Full Text] [Related]
55. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Arnett FC; Reichlin M Am J Med; 1995 Nov; 99(5):465-72. PubMed ID: 7485202 [TBL] [Abstract][Full Text] [Related]
56. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
57. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies. Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701 [TBL] [Abstract][Full Text] [Related]